Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence score

被引：0
|
作者：
Hartkopf, A. [1 ]
Wallwiener, M. [2 ]
Kammoss, S. [1 ]
Brucker, S. [1 ]
Taran, F-A [1 ]
机构：
[1] Univ Tubingen, Tubingen, Germany
[2] Heidelberg Univ, Gynecol & Obstet, Bergheimer Str 58, D-69115 Heidelberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0586
引用
收藏
页码：165 / 165
页数：1
相关论文
共 50 条
  • [31] IMMUNOCYTOCHEMICAL CHARACTERIZATION OF DISSEMINATED TUMOR CELLS FROM BONE MARROW OF BREAST CANCER PATIENTS
    Mumm, J. N.
    Vogl, A.
    Koelbl, A. C.
    Friese, K.
    Jeschke, U.
    Andergassen, U.
    ANTICANCER RESEARCH, 2014, 34 (11) : 6840 - 6840
  • [32] Detection of disseminated tumor cells in the bone marrow of breast cancer patients with a new molecular method
    Banys, Malgorzata
    Krawczyk, Natalia
    Becker, Sven
    Becker-Pergola, Graziella
    Banys, Jerzy
    Krawczyk, Zbigniew
    Wallwiener, Diethelm
    Fehm, Tanja
    GINEKOLOGIA POLSKA, 2012, 83 (08) : 590 - 597
  • [33] Detection of disseminated tumor cells in the bone marrow of breast cancer patients using flow cytometry
    Podyacheva, O.
    Rodionov, V.
    Tupitsyn, N.
    Kometova, V.
    Rodionova, M.
    BREAST, 2017, 32 : S45 - S45
  • [34] Cost-benefit of the 21-gene Breast Cancer Recurrence Score Assay for Patients in Singapore
    Lopes, Gilberto de Lima
    Chien, Rebecca
    Hornberger, John
    BREAST JOURNAL, 2013, 19 (02): : 220 - 221
  • [35] Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen
    Paik, Soonmyung
    ONCOLOGIST, 2007, 12 (06): : 631 - 635
  • [36] Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer
    Laws, Alison
    Garrido-Castro, Ana C.
    Poorvu, Philip D.
    Winer, Eric P.
    Mittendorf, Elizabeth A.
    King, Tari A.
    ONCOLOGY-NEW YORK, 2021, 35 (02): : 77 - 84
  • [37] 21-gene recurrence score and adjuvant chemotherapy decisions in patients with invasive lobular breast cancer
    Chen, Xiang-Hong
    Zhang, Wen-Wen
    Wang, Jun
    Sun, Jia-Yuan
    Li, Feng-Yan
    He, Zhen-Yu
    Wu, San-Gang
    BIOMARKERS IN MEDICINE, 2019, 13 (02) : 83 - 93
  • [38] Comprehensive Association Analysis of 21-Gene Recurrence Score and Obesity in Chinese Breast Cancer Patients
    Tong, Yiwei
    Gao, Weiqi
    Wu, Jiayi
    Zhu, Siji
    Huang, Ou
    He, Jianrong
    Zhu, Li
    Chen, Weiguo
    Li, Yafen
    Shen, Kunwei
    Chen, Xiaosong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysis
    Makower, Della
    Qin, Jiyue
    Lin, Juan
    Xue, Xiaonan
    Sparano, Joseph A.
    NPJ BREAST CANCER, 2022, 8 (01)
  • [40] Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland
    Smyth, Lillian
    Watson, Geoff
    Walsh, Elaine M.
    Kelly, Catherine M.
    Keane, Maccon
    Kennedy, M. John
    Grogan, Liam
    Hennessy, Bryan T.
    O'Reilly, Seamus
    Coate, Linda E.
    O'Connor, Miriam
    Quinn, Cecily
    Verleger, Katharina
    Schoeman, Olaf
    O'Reilly, Susan
    Walshe, Janice M.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (03) : 573 - 582
12345